Logo image of KIDS

ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis

NASDAQ:KIDS - Nasdaq - US68752L1008 - Common Stock - Currency: USD

25.61  +2.72 (+11.88%)

After market: 25.61 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to KIDS. KIDS was compared to 188 industry peers in the Health Care Equipment & Supplies industry. The financial health of KIDS is average, but there are quite some concerns on its profitability. KIDS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

KIDS had negative earnings in the past year.
KIDS had a negative operating cash flow in the past year.
In the past 5 years KIDS reported 4 times negative net income.
KIDS had a negative operating cash flow in each of the past 5 years.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

KIDS has a Return On Assets of -5.81%. This is in the better half of the industry: KIDS outperforms 64.36% of its industry peers.
KIDS's Return On Equity of -7.67% is fine compared to the rest of the industry. KIDS outperforms 68.09% of its industry peers.
Industry RankSector Rank
ROA -5.81%
ROE -7.67%
ROIC N/A
ROA(3y)-3.28%
ROA(5y)-5.52%
ROE(3y)-4.15%
ROE(5y)-7.22%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1.3 Margins

The Gross Margin of KIDS (73.68%) is better than 84.04% of its industry peers.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KIDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.11%
GM growth 5Y0.18%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for KIDS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

KIDS has an Altman-Z score of 3.23. This indicates that KIDS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of KIDS (3.23) is better than 70.21% of its industry peers.
KIDS has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
KIDS has a Debt to Equity ratio of 0.20. This is comparable to the rest of the industry: KIDS outperforms 55.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 3.23
ROIC/WACCN/A
WACC8.79%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

KIDS has a Current Ratio of 7.17. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of KIDS (7.17) is better than 87.77% of its industry peers.
KIDS has a Quick Ratio of 3.68. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS's Quick ratio of 3.68 is fine compared to the rest of the industry. KIDS outperforms 72.87% of its industry peers.
Industry RankSector Rank
Current Ratio 7.17
Quick Ratio 3.68
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for KIDS have decreased strongly by -33.41% in the last year.
EPS 1Y (TTM)-33.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.03%

3.2 Future

KIDS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.41% yearly.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.50% yearly.
EPS Next Y10.58%
EPS Next 2Y16.98%
EPS Next 3Y23.41%
EPS Next 5YN/A
Revenue Next Year18.08%
Revenue Next 2Y17.61%
Revenue Next 3Y17.5%
Revenue Next 5YN/A

3.3 Evolution

KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KIDS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as KIDS's earnings are expected to grow with 23.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.98%
EPS Next 3Y23.41%

More info and screens

0

5. Dividend

5.1 Amount

KIDS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (3/5/2025, 8:07:12 PM)

After market: 25.61 0 (0%)

25.61

+2.72 (+11.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-05 2025-05-05/amc
Inst Owners73.31%
Inst Owner Change1.27%
Ins Owners4%
Ins Owner Change-0.02%
Market Cap620.27M
Analysts83.33
Price Target38.96 (52.13%)
Short Float %5.69%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.69%
Min EPS beat(2)-38.31%
Max EPS beat(2)6.92%
EPS beat(4)2
Avg EPS beat(4)-3.8%
Min EPS beat(4)-38.31%
Max EPS beat(4)17.58%
EPS beat(8)5
Avg EPS beat(8)2.7%
EPS beat(12)8
Avg EPS beat(12)21.22%
EPS beat(16)10
Avg EPS beat(16)7.85%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.39%
Max Revenue beat(2)-0.42%
Revenue beat(4)1
Avg Revenue beat(4)0.2%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)4.87%
Revenue beat(8)2
Avg Revenue beat(8)-0.52%
Revenue beat(12)3
Avg Revenue beat(12)-0.92%
Revenue beat(16)5
Avg Revenue beat(16)-0.77%
PT rev (1m)0%
PT rev (3m)-6.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.59%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.27
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB 3.18
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-3.14
FCFYN/A
OCF(TTM)-1.26
OCFYN/A
SpS7.83
BVpS15.31
TBVpS8.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.81%
ROE -7.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.68%
FCFM N/A
ROA(3y)-3.28%
ROA(5y)-5.52%
ROE(3y)-4.15%
ROE(5y)-7.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.11%
GM growth 5Y0.18%
F-Score2
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 224.3%
Cap/Sales 23.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.17
Quick Ratio 3.68
Altman-Z 3.23
F-Score2
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)111.89%
Cap/Depr(5y)147.13%
Cap/Sales(3y)12.43%
Cap/Sales(5y)13.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y10.58%
EPS Next 2Y16.98%
EPS Next 3Y23.41%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%40.03%
Revenue Next Year18.08%
Revenue Next 2Y17.61%
Revenue Next 3Y17.5%
Revenue Next 5YN/A
EBIT growth 1Y-11.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.15%
EBIT Next 3Y50%
EBIT Next 5Y40.43%
FCF growth 1Y-138.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-55.68%
OCF growth 3YN/A
OCF growth 5YN/A